Prevalence of thyroid dysfunction in patients with type 2 diabetes
DOI:
https://doi.org/10.18203/2320-6012.ijrms20194309Keywords:
Hemoglobin A1c, Hypothyroidism, High-density lipoprotein, Low-density lipoprotein, Thyroid Dysfunction, Thyroid stimulating hormone, Type 2 Diabetes, Very-low-density lipoproteinAbstract
Background: Diabetes mellitus, a leading cause of death worldwide, is the most common endocrine disorder. Type 2 Diabetes (T2D) and Thyroid Dysfunction (TD) often present together and complicate each other at many levels. Recent studies find out the prevalence of TD in T2D in Malwa Region. Objective of the purpose of this study was to find out the prevalence of TD in patients with T2D.
Methods: A match cross-sectional study design was conducted at Department of Medicine, Sri Aurobindo Medical College, from March 2018 to April 2019. Source populations were all patients who live in Malwa Region, Indore. A total of 150 cases were enrolled in this study, 75 cases (TD in T2D) and 75 controls were taken into study.
Results: There was no significant difference in age and body mass index (BMI) between groups. The average duration of diabetes was 7.76±5.57 years and mean Hemoglobin A1c (HBA1c) was 8.17±1.66%. Only 29(38.6%) of patients had HbA1c below 7%. There was significant difference (p=0.001) in HbA1c. Prevalence of TD in T2D was significantly more in females. Out of TD in T2D patients, sub-clinical hypothyroid was present in 14.6% hypothyroidism was present in 8% patients and sub-clinical hyperthyroidism and hyperthyroidism was present in 1.3% patients.
Conclusions: This study reveals about one in four people living with T2D are suffering from TD in Malwa Region. TD is common in T2D patients and can produce significant metabolic disturbances.
References
Hage M, Zantout MS, Azar ST. Thyroid disorders and diabetes mellitus. J Thyroid Res. 2011; 2011:439-63.
Han C, He X, Xia X, Li Y, Shi X, Shan Z, et al. Subclinical hypothyroidism and type 2 diabetes: A systematic review and metaanalys is. PLoS One 2015; 10(8):e0135233.
Granner DK. Thyroid hormones. In: Murray RK, Granner DK, Mayes PA, Rodwell VW, editors. Harper’s Biochemistry. London: Prentice Hall International Inc.2000; 25: 533-8.
Gharib H, Tuttle RM, Baskim J, Fish LH, Singer PA, McDermott MT. Consensus statement. Subclinical thyroid dysfunction: A joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association and The Endocrine Society. J Clin Endocrinol Metab. 2005; 90(1):581-5.
Smithson MJ. Screening for thyroid dysfunction in a community population of diabetic patients. Diabet Med. 1998; 15(2):148-50.
Mukherjee S, Datta S, Datta P, Mukherjee AK, Maisnam I. A study of prevalence of primary hypothyroidism in recently diagnosed type 2 diabetes mellitus in a tertiary care hospital. Int J Sci Rep. 2015;1(2):105-12.
Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes. Diabetes Care. 2004; 27(5):1047-53.
Gray RS, Irvine WJ, Clarke BF. Screening for thyroid dysfunction in diabetics. Br Med J. 1979; 2(6202):1439.
Vaidya R. Association of thyroid dysfunction and diabetes mellitus: Is the co-existence incidental? J Obes Metabol Res. 2014;1(2):83-4.
Wu P, MD, FACE, FRCP. Thyroid disease and diabetes. Clin Diabetes. 2000;18(1):38.
Shah SN. Thyroid disease in diabetes mellitus. J Assoc Physicians India. 1984;32(12):1057-9.
Nicholas A. Type 2 diabetes mellitus and thyroid dysfunction: An intertwined duo. Afr J Diabetes Med. 2015;22:5-7.
Aschner P. New IDF clinical practice recommendations for managing type 2 diabetes in primary care; 2017. Accessed 23.5.2019.
Gardas A. Laboratory tests: level of T3, T4, TSH and antithyroid gland autoantibodies in the Polish population. Endo Krynol Pol. 1991;42(2):353-8.
Somwaru LL, Arnold AM, Joshi N, Fried LP, Cappola AR. High frequency of and factors associated with thyroid hormone over-replacement and under-replacement in men and women aged 65 and over. J Clin Endocrinol Metab. 2009;94(4):1342-5.
Gurjeet S, Vikas G, Anu Kumar S, Neeraj G. Evaluation of thyroid dysfunction among type 2 diabetic Punjabi population. Adv Biores. 2011; 2(2):3‑9.
Kumar RA, Narasimhasetty KR, Lalitha R, Shetty SB. Prevalence of thyroid dysfunction among type 2 diabetes subjects in South India. Inter J Clin Cases and Investigations. 2013;5(6):93-100.
Chaturvedi S, Nagtilak S, Parashar P, Rastogi A, Gupta A. Thyroid dysfunction and it’s relation with Type 2 diabetes mellitus in Meerut. Int J Sci Res. 2016;7:305-7.
Perros P, McCrimmon RJ, Shaw G, Frier BM. Frequency of thyroid dysfunction in diabetic patients: value of annual screening. Diabet Med. 1995;12(7):622-7.
Anveetha P, Rao KP, Chittimoju VK. Study of thyroid profile in patients with type 2 diabetes mellitus. Int J Pharm Biol Sci. 2015;5:24-30.
Chandel K, Singh RB, Kumar S, Gupta A, Nath K. Evaluation of thyroid hormone dysfunction in patients of type 2 diabetes mellitus. Indian J Clin Anat Physiol. 2016;3(1):21-3.
Diez JJ, Sanchez P, Iglesias P. Prevalence of thyroid dysfunction in patients with type 2 diabetes. Exp Clin Endicrinol Diabetes. 2011; 119(4):201-7.
Proces S, Delgrange E, Vander BTV, Jamart J, Donckier JE. Minor alterations in thyroid function tests associated with diabetes mellitus and obesity in outpatients without known thyroid illness. Acta Clin Belg. 2001;56(2):86-90.
Schlienger JL, Anceau A, Chabrier G, North ML, Stephan F. Effect of diabetic control on the level of circulating thyroid hormones. Diabetologia. 1982; 22(6):486-8.
Bazrafshan HR, Ramezani A, Salehi A, SHIR AA, Mohammadian S, Rais ZF, et al. Thyroid dysfunction and its relation with diabetes mellitus (NIDDM). J Gorgan Univ Med Sci. 2000;2(1):5-11.
